BiotechTubeBiotechTube
Home/Aucta Pharmaceuticals/Changjun Liu
CL

Changjun Liu

Vice President, Quality Management

Aucta Pharmaceuticals

Therapeutic Areas

Central Nervous System (CNS) DisordersMetabolic DiseasesOrphan and Specialty IndicationsOphthalmicsDermatologyPediatrics

Aucta Pharmaceuticals Pipeline

DrugIndicationPhase
Motpoly XR™EpilepsyNot Specified (Likely Phase 3/NDA)
CNS Pipeline CandidatesCentral Nervous System DisordersNot Specified
Orphan/Specialty Pipeline CandidatesOrphan and Specialty IndicationsNot Specified
Metabolic Disease CandidatesMetabolic DiseasesNot Specified
Ophthalmics CandidatesOphthalmicsNot Specified
Dermatology CandidatesDermatologyNot Specified
Pediatrics CandidatesPediatricsNot Specified

Leadership Team at Aucta Pharmaceuticals

SL
Shoufeng Li, Ph.D.
Chief Executive Officer, Founder, Scientist
BZ
Brian Zorn, Pharm.D.
Executive Director
QR
Qiaolin Ren, Ph.D.
Vice President
LL
Lisheng Lu
Executive Director and Vice President of Manufacture (China)
RL
Rong Li, Ph.D.
Scientific Advisor
CJ
Chris Jarman
Vice President, Managed Markets and Operations
LG
Lixin Gong
Head of Analysis
View full Aucta Pharmaceuticals profile